“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
On May 18, 2020, Moderna, Inc. of Cambridge, Massachusetts announced that it had obtained “positive interim clinical data” from a Phase I human clinical trial of its experimental mRNA-1273 COVID-19 vaccine that began on Mar. 16. The biotechnology company said that eight of the 45 healthy adult volunteer trial subjects developed antibodies that may provide […]
Julie Gerberding, MD, who served as director of the U.S. Centers for Disease Control and Prevention (CDC) from 2002 to 2009,1 2 and joined Merck & Co. as president of Merck Vaccines division in January 2010,3 4 recently sold 102,073 shares of her Merck stock for approximately $$9.119 million. This represented just under half of […]
The New York Times on Feb. 6, 2020 was the first mainstream media outlet to report that Chinese government authorities responding to the country’s coronavirus epidemic had ordered round-the-clock house to house police searches to take the temperatures of all residents in Wuhan and detain anyone found to be sick or suspected of being sick […]
Story Highlights The Vaccine Adverse Event Reporting System (VAERS) was created by Congress in 1986 as part of the National Childhood Vaccine Injury Act. Although health care providers are required by federal law to report specific vaccine reactions to VAERS, less than one percent of adverse events following vaccination are reported. Doctors, medical workers, adult patients […]
Alpha-gal syndrome (AGS), the delayed, potentially fatal red meat allergy acquired through tick bites, has increased dramatically in the United States, and cases have also been reported in Sweden, Germany and Australia.1 As of 2013, more than 5,000 people in the Southwest U.S. have been diagnosed with the condition.2 In 2007, Scott Commins, MD, an […]